# Polyplus-transfection

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/polyplus-transfection

- Industry: Biotechnology
- Headquarters: France
- Website: www.polyplus-transfection.com
- Total disclosed funding: $5.8M
- Latest round: Series D (Jul 19, 2013)
- Investors on record: 6

## About

Polyplus-transfection SA specializes in innovative solutions for nucleic acid delivery and biologics manufacturing, particularly focusing on cell and gene therapies to enhance transfection efficiency and yield.Founded in 2001 in France, Polyplus-transfection SA is dedicated to developing high-performance transfection solutions for the biotechnology sector. The company has undergone strategic adjustments to strengthen its market position and was recently acquired by Sartorius AG from ARCHIMED and Warburg Pincus for EUR 2.4 billion on March 31, 2023. The leadership includes CEOs Mario Philips and Mark Bloomfield.Polyplus® offers a wide range of transfection reagents, including FectoVIR® for lentiviral and AAV vector production, and in vivo-jetRNA®+ for mRNA delivery. Their products are designed to enhance transfection efficiency and are used primarily by biopharmaceutical companies and research institutions. Additionally, Polyplus® provides plasmid manufacturing services, adhering to stringent GMP-grade requirements, and serves clients globally across North America, Europe, and Asia.In the most recent year, Polyplus® reported a revenue of EUR 4,721,870.20 with an EBITDA of EUR 1,393,832.60, generated through B2B sales of specialized products and services tailored to the biotechnology and pharmaceutical sectors.The recent acquisition by Sartorius AG positions Polyplus-transfection SA to enhance its offerings for cell and gene therapy companies. The acquisition is expected to facilitate expansion into new markets and bolster product development initiatives. Funding from this transaction will be utilized to strengthen their capabilities in supplying cutting-edge solutions for the biotechnology sector.

## Funding rounds

- Series D, Jul 19, 2013, $0.2M — TechFund Capital Europe Management, Sudinnova, Credit Mutuel Equity, Aqua Asset Management, Vizille Capital Innovation
- Series C, May 17, 2011, $4.3M — TechFund Capital Europe Management, Credit Mutuel Equity, Vizille Capital Innovation
- Series B, Sep 20, 2004, $1.3M — Aqua Asset Management, Vizille Capital Innovation, Finances & Stratégies

## Investors

- Aqua Asset Management (https://capitalatlas.ai/funds/aqua-asset-management) — Series B, Series D
- Vizille Capital Innovation — Series B, Series C, Series D
- Finances & Stratégies — Series B
- TechFund Capital Europe Management (https://capitalatlas.ai/funds/techfund-capital-europe-management) — Series C, Series D
- Credit Mutuel Equity (https://capitalatlas.ai/funds/credit-mutuel-equity) — Series C, Series D
- Sudinnova (https://capitalatlas.ai/funds/sudinnova) — Series D